IL33 and cancer: In the state of injury, necrosis, or cell stress, IL-33 is released into the extracellular space and binds to its cognate receptor interleukin-1 receptor-like 1 (IL1RL1), which has been associated with tissue and metabolic homeostasis, inflammation, infection, and cancer.